Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ENTX Entera Bio Ltd. Ordinary Shares
$1.27 -11.94% -0.16
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ENTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 73.0M
Enterprise value 53.1M
Trailing PE -4.72
Forward PE -2.3272727
PEG Ratio -2.3272727
Enterprise to EBITDA -4.614
Enterprise to revenue 1263.297
Price to book MRQ 4.507042
Price to sales TTM 1659.4293

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 42000
EBITDA -11499000
Diluted EPS TTM -0.25
Total Cash (MRQ) 7.1M
Current ratio (MRQ) 6.944
Operating Cash Flow (TTM) -7370000

ENTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ENTX News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.